HFMA 2017: Hospital finance execs have ‘significant lack of knowledge’ around MACRA

Nearly halfway through the first year of Medicare Access and CHIP Reauthorization Act’s (MACRA) new payment tracks and hospital, a majority of hospital finance executives and professionals say understand the requirements of the new Quality Payment Program (QPP) but, in reality, still seem to be confused.

In a survey conducted by Nuance Communications released at the Healthcare Financial Management Association (HFMA) conference in Orlando, 61 percent of respondents said they’re confident they understand QPP requirements. Those include the low-volume exclusion thresholds, how many quality measures they must report and what “pick your pace” options within the Merit-based Incentive Payment System (MIPS) are available in 2017. 56 percent said they’re confident their organizations can meet those requirements.

Asking about specific requirements, however, revealed the confidence of finance executives may be misplaced. Of those who said they were confident about understanding requirements, 75 percent couldn’t correctly report that eligible providers who didn’t participate in QPP would have their Medicare reimbursements cut by 4 percent in 2019. Most underestimated the risk or didn’t know the answer.

Many also got the submission timing requirements wrong. Of the confident group, only 35 percent knew that QPP requires 90 days of quality data to be submitted.

“Without proper clinical documentation, no organization will do well with QPP,” Anthony Oliva, DO, chief medical officer at Nuance, said in a statement. “While the changes are daunting, it is crucial for hospitals and clinicians to take proactive steps to prepare, plan and participate. Doing so will help organizations retain what they earn in the short term, but will also set them up to avoid severe penalties in the long run.”

Financial professionals haven’t been alone in their confusion over MACRA, QPP, MIPS, and their related programs. A July 2016 survey of physicians conducted by Deloitte found only 9 percent of those employed by hospitals or large practices were somewhat familiar with the law.

One possible explanation for this lack of awareness on the finer points of the law could be financial professionals don’t feel they have to spend time keeping track of regulations when they’re likely to change.

“The overall results reflect that clinicians and other healthcare experts are not confident that the final rule is actually final, and they are conserving time, energy and finances until that is the case,” Nuance’s quality service line director, Cathy Gorman-Klug, RN, MSN, said to HealthExec.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup